Literature DB >> 5312990

Antibiotic-resistant strains of E1 Tor vibrio in the Philippines and the use of furalazine for chemotherapy.

K Kobari, I Takakura, M Nakatomi, S Sogame, C Uylangco.   

Abstract

Among 1109 patients with bacteriologically confirmed El Tor cholera admitted to the San Lazaro Hospital, Manila, in 1969, 11 patients continued to excrete vibrios of the same biotype and serotype in stools for more than 1 week in spite of antibiotic treatment.The strains isolated from these patients all belonged to the Ogawa serotype and were all highly resistant to streptomycin and chloramphenicol, and a few of them were resistant also to tetracycline. Other streptomycin-resistant strains of El Tor vibrio were detected, 5 in the Greater Manila area and 1 in Bacolod.The antibiotic-resistant strains showed a high sensitivity to 3 kinds of antimicrobial chemicals, particularly dihydroxymethyl furalazine.Furalazine was given to 33 adults and 15 children with bacteriologically confirmed cholera, and its effect in reducing the duration of diarrhoea and excretion of vibrios was investigated in comparison with the same number of cases treated with chloramphenicol. Furalazine was more effective in reducing the duration of positive stool culture than chloramphenicol, and the two antimicrobial agents were equally effective in decreasing intravenous fluid requirements.Since furalazine was satisfactory in reducing the duration of diarrhoea and excretion of vibrios in stools, and since no resistant strains were found, the drug could be recommended as an alternative to chloramphenicol and tetracycline in the treatment of cholera.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5312990      PMCID: PMC2427672     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  7 in total

1.  Some observations on the carrier state in cholera.

Authors:  M A GOHAR; A EL-MOFTY; A A EISSA; A H MOUSA; A SOROUR; H DOSS; T GOMA; M ABOU EL-WAFA; A EL-AZHARI; S MITRI; M IBRAHIM
Journal:  J Trop Med Hyg       Date:  1952-11

2.  Furazolidone in the treatment of cholera.

Authors:  R N Chaudhuri; K N Neogy; S N Sanyal; R K Gupta; P Manji
Journal:  Lancet       Date:  1968-02-17       Impact factor: 79.321

3.  The drug-sensitivity of isolates from cholera El Tor patients in San Lazaro Hospital, Manila.

Authors:  T P Pesigan; C Z Gomez; D Barua
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

4.  Amphetamine.

Authors:  H J Roberts
Journal:  Lancet       Date:  1965-10-30       Impact factor: 79.321

5.  Drug-sensitivity of El Tor vibrio strains isolated in the Philippines in 1964 and 1965.

Authors:  S Kuwahara; S Goto; M Kimura; H Abe
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

6.  Furazolidone in paediatric cholera.

Authors:  A W Karchmer; G T Curlin; M I Huq; N Hirschhorn
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

7.  Observations on cholera treated orally and intravenously with antibiotics. With particular reference to the number of vibrios excreted in the stool.

Authors:  K Kobari; C Uylangco; J Vasco; Y Takahira; N Shimizu
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408

  7 in total
  5 in total

1.  Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers.

Authors:  Amber Kunkel; Joseph A Lewnard; Virginia E Pitzer; Ted Cohen
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

2.  The prevalence and genetics of resistance to commonly used antimicrobial agents in faecal Enterobacteriaceae from children in Bangladesh.

Authors:  K Z Mamun; P Shears; C A Hart
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

3.  Development of plasmid-mediated resistance in Vibrio cholerae during treatment with trimethoprim-sulfamethoxazole.

Authors:  M J Dupont; M Jouvenot; G Couetdic; Y Michel-Briand
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

4.  Temperature-sensitive R plasmid obtained from naturally isolated drug-resistant Vibrio cholerae (biotype El Tor).

Authors:  T Yokota; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

5.  Hybrid Vibrio cholerae El Tor lacking SXT identified as the cause of a cholera outbreak in the Philippines.

Authors:  David C Klinzing; Seon Young Choi; Nur A Hasan; Ronald R Matias; Enrique Tayag; Josefina Geronimo; Evan Skowronski; Shah M Rashed; Kent Kawashima; C Nicole Rosenzweig; Henry S Gibbons; Brian C Torres; Veni Liles; Alicia C Alfon; Maria Luisa Juan; Filipinas F Natividad; Thomas A Cebula; Rita R Colwell
Journal:  MBio       Date:  2015-04-21       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.